Redeye: Lifco Q3 2024 - Solid Q3 figures, overdue correction
Redeye updates its estimates and valuation following Lifco releasing its Q3 2024 report. While we judge Q3 figures were solid and roughly aligned with our expectations, we believe Mr Market priced the share for perfection before the third-quarter report release. We make minor changes to our estimates and valuation and consider earnings growth to be the primary driver of Lifco’s share. Our view of the investment case remains unchanged.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/